Blog
Insights on launching and scaling insurance-contracted behavioral health programs.
March 18, 2026
SimplePractice vs Growing Behavioral Health Group Practices
SimplePractice works great for solo therapists but hits hard limits for growing group practices. Here's when you've outgrown it and what to do next.
March 18, 2026
AthenaHealth Problems for Behavioral Health Groups
AthenaHealth problems for behavioral health groups: HCPCS billing gaps, 42 CFR Part 2 compliance issues, group therapy documentation challenges, and better EHR alternatives.
March 17, 2026
Meaningful Use & Interoperability in Behavioral Health
Learn what meaningful use and interoperability actually mean for behavioral health providers. Practical guide to EHR requirements, 42 CFR Part 2, and care coordination.
March 17, 2026
How Noisy Charts Hurt Your Treatment Center's Bottom Line
Noisy charts cost treatment centers thousands in denials. Learn how copy-paste notes, contradictory documentation, and chart clutter trigger payer rejections.
March 17, 2026
5 Mistakes When Opening an Addiction Treatment Group Practice
Avoid the 5 costly mistakes opening addiction treatment group practice: partnership agreements, credentialing, employee classification, supervision, and cash flow.
March 17, 2026
Boost Patient Portal Engagement at Your Treatment Center
Low patient portal adoption costs your treatment center time and outcomes. Learn the exact workflows to drive portal engagement from intake through alumni care.
March 17, 2026
Treatment Center Real Estate: A Behavioral Health Guide
Behavioral health treatment center real estate guide: zoning, lease negotiation, facility requirements, IOP/PHP space needs, and scaling strategies for operators.
March 17, 2026
Digital Therapeutics for Addiction Treatment: What to Know
Digital therapeutics addiction treatment 2026: FDA-cleared prescription tools like reSET, reimbursement reality, and how to integrate DTx into your program.
March 17, 2026
Psychedelics in Behavioral Health: Timeline & Opportunities
Psychedelic treatments in addiction and behavioral health 2026: evidence-based breakdown of psilocybin, MDMA, ketamine, and ibogaine for treatment center operators.